Navigation Links
CombinatoRx Provides Topline Results from Phase 2 RA Study with,CRx-139 and Very Low Dose Prednisolone

ich provides a renewable and previously untapped source of novel drug candidates. The Company was founded in 2000 and is located in Cambridge, Massachusetts. To learn more about CombinatoRx please visit www.combinatorx.com.

Forward-Looking Statement

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 concerning CombinatoRx, its product candidates and their clinical potential, its plans for its product candidates, its formulation efforts, its business plans and its drug discovery technology. These forward-looking statements about future expectations, plans and prospects of CombinatoRx involve significant risks, uncertainties and assumptions, including risks related to the unproven nature of the CombinatoRx drug discovery technology, the Company's ability to initiate and successfully complete clinical trials of its product candidates, risks associated with developing modified-release formulations of its product candidates, assumptions regarding the mechanism of action of our product candidates, potential difficulty and delays in obtaining regulatory approval for the sale and marketing of its product candidates, the Company's ability to obtain additional funding for its research and development and those other risks that can be found in the "Risk Factors" section of the CombinatoRx Annual Report Form 10-K on file with the Securities and Exchange Commission and the other reports that CombinatoRx periodically files with the Securities and Exchange Commission. Actual results may differ materially from those CombinatoRx contemplated by these forward looking statements. CombinatoRx does not undertake to update any of these forward-looking statements to reflect a change in its views or events or circumstances that occur after the date of this release.

(C) 2007 CombinatoRx, Incorporated. All rights reserved.

Contact

CombinatoRx, Incorporated
Robert Forrester,
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. CombinatoRx Product Candidate CRx-150 Shows Activity on DAS28 and Pain, but Not CRP
2. Additional Data on CombinatoRx Drug Candidates CRx-102 and CRx-139 Presented at EULAR
3. Novel Mechanism Insights and Additional Data on CombinatoRx Drug Candidates to Be Presented at Upcoming EULAR Meeting
4. CombinatoRx to Present Combination High Throughput Screening (cHTS) Data at Upcoming AACR Meeting
5. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
6. XTL Provides Update on Phase I Clinical Trial of XTL-2125
7. Cervarix, the GSK Cervical Cancer Candidate Vaccine, Provides Sustained Immune Response in 100 Percent of Women up to 55 Years of Age
8. Daytrana (methylphenidate transdermal system) Provides Significant Effectiveness in ADHD Symptom Relief in Both Boys and Girls
9. DURECT Provides an Update to the Memryte Program Under Development by Voyager Pharmaceutical Corp
10. NicOx Provides an Update on the Phase 2a Study for NCX 1000 Conducted With Axcan
11. Indivumed Study Provides Sound Scientific Basis for a Predictive Drug Test- Platform

Post Your Comments:
(Date:11/20/2009)...e-FirstCall/ -- Smith & Nephew ( SNN, LSE: SN)...signing of a technology development contract with ...ead to the creation of a fracture fixation system ...bs of soldiers who sustain battlefield injuries. ,...ects Agency (DARPA), the central research and deve...
(Date:11/19/2009)...-- In response to an ever-increasing number of web...peration Pangea II, involving 24 countries, was co...ation,s International Medical Products Anti-Counte...rs of buying medicines online. ,, The week long... and the seizure of thousands of potentially harmf...
(Date:11/19/2009)...- Riverain Medical announced today that the compan... imaging distributor Christie Group to offer SoftV...CAD. The exclusive agreement will bring Dayton, Oh...an market through Christie Group,s established and...Chest Imaging increases the clarity of digital che...
Breaking Medicine Technology:Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 2Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 3Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 4International Operation Combats Online Supply of Counterfeit and Illegal Medicines 2Riverain Medical Partners With The Christie Group In Canada To Offer SoftView Enhanced Chest Imaging and OnGuard Chest X-Ray CAD Technologies 2New Complimentary Wallet Card to Tackle Concussions Head On 58903 1New Complimentary Wallet Card to Tackle Concussions Head On 58903 2Hugh Chatham Adopts Star Trek Technology with the Use of Palm Identify to Prevent Medical ID Theft 58898 1Hugh Chatham Adopts Star Trek Technology with the Use of Palm Identify to Prevent Medical ID Theft 58898 2U S FDA Authorizes Expansion to 40 Clinical Sites for HeartWare U S Bridge to Transplant Clinical Trial 5241 1U S FDA Authorizes Expansion to 40 Clinical Sites for HeartWare U S Bridge to Transplant Clinical Trial 5241 2U S FDA Authorizes Expansion to 40 Clinical Sites for HeartWare U S Bridge to Transplant Clinical Trial 5241 3
...Enrollment in First Pivotal Phase 3 Avanafil Study...Calif., May 13 VIVUS, Inc. (Nasdaq: VVUS ), a b...xt-generation therapies to address unmet needs in ...ed that it has initiated an open label safety stud..., in males with erectile dysfunction (ED). , , ...
...WASHINGTON, May 12 The Epilepsy Foundation recent...sy, whose seizures have been controlled with a con...reased seizures, greater side effects or sudden de...ersion of an antiepileptic drug (AED) to another, ...o-brand or generic-to-generic. , , See video fro...
Other Medicine Technology:VIVUS Initiates Open Label Safety Study of Avanafil for Erectile Dysfunction 2VIVUS Initiates Open Label Safety Study of Avanafil for Erectile Dysfunction 3VIDEO from Medialink and the Epilepsy Foundation: New Study Suggests Different Versions of the Same Epilepsy Medication Can Be Harmful 2
(Date:11/22/2009)...-- Physician-scientists from Weill Cornell Medical...t may prove to be a powerful target for the treatm...at affects lymphocytes, or white blood cells. By e...le to powerfully suppress tumor formation in lab t... have led to the design of a clinical trial that w...
(Date:11/22/2009)...ep eating under control, expert says , ,...eason means you,ll be faced with a seemingly endle...mply give in and eat too much, others deny themsel... navigate between overindulgence and deprivation, ...onsult Services at Brigham and Women,s Hospital in...
(Date:11/22/2009)...The holiday season is filled with get-togethers wi...us. It can also be stressful and tiring at times. ...igue, and high fat foods -- factors that can, over...e National Foundation for Cancer Research has deve...ure a happier, more healthful holiday season, and ...
(Date:11/22/2009)... 21 Congressman Chaka F...he United States Senate,s vote tonight to proceed ..., "Senators Arlen Specter and Bob Casey deserve...ns for casting stand-up, critical votes in the Sen...ffordable Health Care Reform legislation to full d...
(Date:11/21/2009)...v. 21 DNC Chairman Tim ...ate voted to begin full debate of health insurance...scom.com/cgi-bin/prnh/20080519/DNCLOGO ) ,, "...e road to enacting health insurance reform. By cle...now have an opportunity to debate the health refor...
Breaking Medicine News(10 mins):Health News:New cancer target for non-Hodgkin's lymphoma 2Health News:Go Healthy, Not Hungry for Holiday Eating 2Health News:Top 10 Food Tips for the Holidays from the National Foundation for Cancer Research 2Health News:Top 10 Food Tips for the Holidays from the National Foundation for Cancer Research 3Health News:Democratic National Committee Chairman Tim Kaine's Statement on the Senate's Vote to Proceed to Full Floor Debate of Health Insurance Reform Legislation 2
...epeatedly failing to implement rules that will red...s //from contaminated surgical instruments. ...g instruments in sets so they can be traced easily... that surgical instruments were not contaminated a...
...ood rich in carbohydrates was very effective in ma.... The study results are to be presented at the Aus... Incorporated Convention in Adelaide. The stud...eeks. She and her team of researchers in the e...
...ns involved in the HIV/AIDS campaign plan to hold ...dia // tomorrow to protest the government's Drug P...DS medication at risk. The organisers will be...ment, the Indian government is considering adding ...
...rted declining, aid agencies warn Angola of repeat...sues are not addressed//. Karen Godley, the Me...ission in Angola said, "The government needs to im... latest World Health Organisation report of the ch...
... concerns over the practice of "Breast Ironing" i...prevalent and is used to stunt breast growth in gi...that it is for their own good. It is aimed a... is an age-old practice in Cameroon, as well as in...
... introduce new legislation to regulate doctors, du... She is seeking Government approval in order to pu...or the following week so that a new Medical Practi... years, it is finally expected that new legislatio...
Other Medicine News:
...laboratory and a worldwide leader in innovative la...extensive test menu of highly complex and unique m...wned by the University of Utah, ARUP Laboratories'...iversity teaching hospitals and children's hospita...
...laboratory and a worldwide leader in innovative la...extensive test menu of highly complex and unique m...wned by the University of Utah, ARUP Laboratories'...iversity teaching hospitals and children's hospita...
...laboratory and a worldwide leader in innovative la...extensive test menu of highly complex and unique m...wned by the University of Utah, ARUP Laboratories'...iversity teaching hospitals and children's hospita...
...laboratory and a worldwide leader in innovative la...extensive test menu of highly complex and unique m...wned by the University of Utah, ARUP Laboratories'...iversity teaching hospitals and children's hospita...
Medicine Products: